Sirius Medical

Sirius Medical improves care for cancer patients. It offers unsurpassed solutions, enabling accurate and efficient removal of tumours.

Introduction

In portfolio since September 2020

Healthcare

Venture & Growth

Add ons

  • Praktische GGZ
  • ad Astra

About Sirius Medical

Sirius Medical, founded in February 2017, is a spin-off of Antonie van Leeuwenhoek Hospital and the University of Twente, with the goal of improving the health of breast cancer patients. It provides unique, affordable solutions that enable accurate and efficient surgical removal of tumors. Sirius Pintuition was developed by and for surgeons who were convinced that current treatment could be better and more convenient.

Sirius Medical has developed a method in which a magnetic marker -a Pintuition “seed” as small as a grain of rice – is placed in the tumor days to weeks prior to surgery. During surgery, the Pintuition Detector provides real-time millimeter-accurate guidance to the Pintuition ‘seed’.

Why are we investing in Sirius Medical?

Holland Capital is investing with support from existing investors BOM Brabant Ventures, Curie Capital, Team Holmium, Norgine Ventures and a large investment from Sirius Medical’s management and team.

The funding will accelerate the global growth of the Pintuition product and support further product development.

Add on

“We believe that the Pintuition technology and its future innovations will significantly improve the surgery of non-feeling tumors for patients and physicians and improve care for cancer patients.”

Healthcare portfolio

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411

 

Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 96290120